ICLR Competitors & Alternatives
Compare ICON PLC with similar stocks in the same industry
Diagnostics & Research
ICLR
Main Stock$185.43
Tradestie Score
47
Market Cap
$14.96B
P/E Ratio
195.0
Revenue Growth
0.0%
Analyst Upside
+1.5%
Top Competitors
36 stocks in Diagnostics & Research| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
DGX
Quest Diagnostics Inc.
|
$243.28
|
$20.36B | 25.4 | 65 | Compare |
|
WST
West Pharmaceutical Services, Inc.
|
$394.03
|
$19.52B | 50.4 | 41 | Compare |
|
WAT
Waters Corp
|
$455.59
|
$19.04B | 112.1 | 39 | Compare |
|
ILMN
Illumina Inc
|
$269.40
|
$15.72B | 52.8 | 45 | Compare |
|
MEDP
Medpace Holdings, Inc. Common Stock
|
$653.96
|
$15.28B | 36.8 | 46 | Compare |
|
EXAS
Exact Sciences Corp
|
$104.91
|
$10.68B | - | 52 | Compare |
|
RVTY
Revvity, Inc.
|
$157.36
|
$10.65B | 74.6 | 46 | Compare |
|
QGEN
QIAGEN N.V.
|
$50.22
|
$10.04B | 25.4 | 46 | Compare |
|
CRL
Charles River Laboratories International, Inc.
|
$339.66
|
$8.39B | - | 38 | Compare |
|
GH
Guardant Health, Inc. Common Stock
|
$162.94
|
$7.81B | - | 67 | Compare |
More ICLR Analysis
Data updated: Oct 22, 2026 | Industry: Diagnostics & Research (SIC 8731)
36 stocks in this industry